Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should ExpectZacks Investment Research • 10/29/25
Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick SpeciesPRNewsWire • 10/27/25
Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite loomsReuters • 10/24/25
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in DogsPRNewsWire • 10/24/25
Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 10/22/25
Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 10/08/25
Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results AnnouncementPRNewsWire • 10/01/25
Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 09/30/25
Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease LanguagePRNewsWire • 09/23/25
Elanco Animal Health Incorporated (ELAN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/09/25
Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster StatusPRNewsWire • 09/08/25
Splenda® Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and EducationPRNewsWire • 08/27/25
Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600PRNewsWire • 08/26/25
Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare ConferencePRNewsWire • 08/26/25
Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual OutlookBenzinga • 08/07/25
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 08/06/25
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy DogsPRNewsWire • 07/24/25